Skip to content

Clinical trials

Inflammatory Bowel Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Clear all

1,545 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
200210
20036
200412
200510
200617
200722
200828
200935
201031
201143
201248
201355
201462
201569
201666
201790
201881
201998
202089
2021108
2022107
202396
2024115
2025118
2026111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed686
Unknown status277
Recruiting232
Terminated116
Not yet recruiting110
Active, not recruiting50
Withdrawn45
Enrolling by invitation21
Suspended7
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University44
Takeda22
Assistance Publique - Hôpitaux de Paris14
Fondazione Policlinico Universitario Agostino Gemelli IRCCS13
Massachusetts General Hospital13
Pfizer12
University of British Columbia12
Chinese University of Hong Kong11
Icahn School of Medicine at Mount Sinai11
Tanta University11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases1,545
Colitis, Ulcerative614
Crohn Disease597
Irritable Bowel Syndrome49
Colitis46
Gastrointestinal Diseases44
Colorectal Neoplasms42
Intestinal Diseases34
Digestive System Diseases32
Arthritis, Rheumatoid29

Trials

Showing 76 to 100 of 1,545. Each trial links to its page on Pharma Observatory.

1,445 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.